Evaluation of extended interval dosing aminoglycosides in the morbidly obese population

Advances in Pharmacological Sciences

Volumn 2013, Issue , 2013, Pages

  Ross, Ashley L ^a   Tharp, Jennifer L ^b   Hobbs, Gerald R ^c   McKnight, Richard ^c   Cumpston, Aaron ^c  

^a JEWISH HOSPITAL   (United States)

^b Johnson City Medical Center   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; TOBRAMYCIN;

ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DOSE SEQUENCE; EVALUATION; FEMALE; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 84884238899     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2013/194389     Document Type: Article

References (28)

1. The World Health Organization, Obesity Fact Sheet. March 2013, http://www.who.int/topics/obesity/en/
2. Centers for Disease Control and Prevention, Adult Obesity Facts. March 2013, http://www.cdc.gov/obesity/data/adult.html
3. Pai M. P., Bearden D. T., Antimicrobial dosing considerations in obese adult patients: insights from the society of infectious diseases pharmacists. Pharmacotherapy 2007 27 8 1081 1091 2-s2.0-34547431719 10.1592/phco.27.8.1081
4. Newman D., Scheetz M. H., Adeyemi O. A., Montevecchi M., Nicolau D. P., Noskin G. A., Postelnick M. J., Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual. Annals of Pharmacotherapy 2007 41 10 1734 1739 2-s2.0-34748828497 10.1345/aph.1K256
5. Lee J. B., Winstead S., Cook A. M., Pharmacokinetic alterations in obesity. Orthopedics 2006 29 11 984 988 2-s2.0-33845909601
6. Cheymol G., Clinical pharmacokinetics of drugs in obesity-an update. Clinical Pharmacokinetics 1993 25 2 103 114 2-s2.0-0027223897
7. Viriyayudhakorn S., Thitiarchakul S., Nachaisit S., Ho P. C., Wanwimolruk S., Pharmacokinetics of quinine in obesity. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000 94 4 425 428 2-s2.0-0033839119
8. Cheymol G., Effects of obesity on pharmacokinetics: implications for drug therapy. Clinical Pharmacokinetics 2000 39 3 215 231 2-s2.0-0033800745
9. Lind M. J., Margison J. M., Cerny T., Thatcher N., Wilkinson P. M., Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution. Cancer Chemotherapy and Pharmacology 1989 25 2 139 142 2-s2.0-0024367984 10.1007/BF00692355
10. Lotia S., Bellamy M. C., Anaesthesia and morbid obesity. Continuing Education in Anaesthesia, Critical Care and Pain 2008 8 5 151 156 2-s2.0-52749095423 10.1093/bjaceaccp/mkn030
11. Blouin R. A., Bauer L. A., Miller D. D., Vancomycin pharmacokinetics in normal and morbidly obese subjects. Antimicrobial Agents and Chemotherapy 1982 21 4 575 580 2-s2.0-0019965058
12. Sketris I., Lesar T., Zaske D. E., Cipolle R. J., Effect of obesity on gentamicin pharmacokinetics. Journal of Clinical Pharmacology 1981 21 7 288 293 2-s2.0-0019452920
13. Bearden D. T., Rodvold K. A., Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics. Clinical Pharmacokinetics 2000 38 5 415 426 2-s2.0-0034106774
14. Erstad B. L., Dosing of medications in morbidly obese patients in the intensive care unit setting. Intensive Care Medicine 2004 30 1 18 32 2-s2.0-0742269741 10.1007/s00134-003-2059-6
15. Schwartz S. N., Pazin G. J., Lyon J. A., A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects. Journal of Infectious Diseases 1978 138 4 499 505 2-s2.0-0018125595
16. Blouin R. A., Warren G. W., Pharmacokinetic considerations in obesity. Journal of Pharmaceutical Sciences 1999 88 1 1 7 2-s2.0-0032956432 10.1021/js980173a
17. Wurtz R., Itokazu G., Rodvold K., Antimicrobial dosing in obese patients. Clinical Infectious Diseases 1997 25 1 112 118 2-s2.0-0030737521
18. Rea D. J., Heimbach J. K., Grande J. P., Textor S. C., Taler S. J., Prieto M., Larson T. S., Cosio F. G., Stegall M. D., Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney International 2006 70 9 1636 1641 2-s2.0-33750216539 10.1038/sj.ki.5001799
19. Bosma R. J., Krikken J. A., Homan van der Heide J. J., De Jong P. E., Navis G. J., Obesity and renal hemodynamics. Contributions to Nephrology 2006 151 184 202 2-s2.0-33748079482 10.1159/000095329
20. Bauer L. A., Drew Edwards W. A., Patchen Dellinger E., Simonowitz D. A., Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. European Journal of Clinical Pharmacology 1983 24 5 643 647 2-s2.0-0020625997
21. Traynor A. M., Nafziger A. N., Bertino J. S. Jr., Aminoglycoside dosing weight correction factors for patients of various body sizes. Antimicrobial Agents and Chemotherapy 1995 39 2 545 548 2-s2.0-0028870538
22. Pai M. P., Nafziger A. N., Bertino J. S. Jr., Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients. Antimicrobial Agents and Chemotherapy 2011 55 9 4006 4011 2-s2.0-80051820779 10.1128/AAC.00174-11
23. Vincent F., El-Khoury N., Rondeau E., El Solh A. A., Renal function in critically ill, morbidly obese patients. American Journal of Respiratory and Critical Care Medicine 2004 169 12 1332 1333 2-s2.0-3442879546
24. Spinler S. A., Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Annals of Pharmacotherapy 1998 32 12 1275 1283 2-s2.0-0032423228 10.1345/aph.18122
25. Salazar D. E., Corcoran G. B., Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. American Journal of Medicine 1988 84 6 1053 1060 2-s2.0-0023943265
26. Dionne R. E., Bauer L. A., Gibson G. A., Griffen W. O. Jr., Blouin R. A., Estimating creatinine clearance in morbidity obese patients. American Journal of Hospital Pharmacy 1981 38 6 841 844 2-s2.0-0019583094
27. Nicolau D. P., Freeman C. D., Belliveau P. P., Nightingale C. H., Ross J. W., Quintiliani R., Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrobial Agents and Chemotherapy 1995 39 3 650 655 2-s2.0-0028925096
28. Gilbert D. N., Lee B. L., Dworkin R. J., Leggett J. L., Chambers H. F., Modin G., Täuber M. G., Sande M. A., A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. American Journal of Medicine 1998 105 3 182 191 2-s2.0-0032169380 10.1016/S0002-9343(98)00244-7